Physical Functioning Following Total Hip Arthroplasty

Step Execution, Stability, Quality of Life, Fear of Falling and Their Association Following Total Hip Arthroplasty

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00651430

Enrollment

Registered

2008-04-02

Start date

2008-03-31

Completion date

2010-05-31

Last updated

2010-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthrosis, Balance Control, Voluntary Movement Control

Keywords

Balance, Voluntary stepping, function, disability, fear of falls, Total Hip Arthroplasty

Brief summary

Adults suffer from Osteoarthrosis of hip joint that willing to participate in the study will be tested with well-established measuring techniques of Balance control using force plate before 3 month and 6 month after Total Knee Arthroplasty (THA) in the movement and Rehabilitation Laboratory at BGU. An automated algorithm will be used to extract standardized stabilogram-diffusion parameters from each of the COP data sets collected during quiet standing. These parameters include diffusion coefficients, critical displacement, critical time and scaling exponents for both lateral and anterior-posterior sway directions (Collins & De Luca, 1993). Each of the Times (before 3 month and 6 month after the THA) in two task conditions (eyes closed and eyes close conditions). Participants will be required to stand on the platform 10 times for 30 s For each trial, they will be instructed to sway as little as possible. In addition step execution test and Late life function and disability questionnaires will be also examined.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

40 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* Able to stand safely for 30 seconds * Able to walk independently * Hip OA prior THA

Exclusion criteria

* Stroke or other neurological diseases * Minimal score 24 or higher * Blindness

Design outcomes

Primary

Measure	Time frame
SDF parameters	before, 3 month and 6 month after the THA

Secondary

Measure	Time frame
Late Life Function and disability, Fall efficacy scale, step execution test	before 3 month and 6 month after

Countries

Israel

Outcome results